August 14, 2007
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Principal Investigator
Sherry I. Backus PT, DPT, MA
Co-Investigators
Robin Stoller M.S., P.T.
Frank A. Cordasco, MD
Howard Hillstrom, Ph.D
Doreen Stiskal, PhD
Lee Cabel, PhD
Summary
24 subjects with anterior shoulder instability will undergo one testing session of approximately 1 hour 15 minutes with no follow-up session. Subjects will have the EMG activity of 10 shoulder girdle muscles tested using a combination of fine wire and surface electrodes during three isokinetic movement patterns (Scaption, IR/ER @ 45 and 90 degrees abduction) over three conditions: baseline (no intervention), McConnell shoulder taping for anterior shoulder instability and sham taping (placebo). Outcome variables include EMG amplitude and onset time and torque production over the three conditions. This study is designed to determine the efficacy of using shoulder taping for the treatment of non-surgical anterior shoulder instability.
Inclusion/Exclusion Criteria
Inclusion criteria:
Exclusion Criteria:
Contact Information
Sherry I Backus P.T, DPT, MA
backuss@hss.edu
212.606.1215
Robin Stoller M.S., P.T.
212.675.8355